Overview of the pharmacogenomics of cigarette smoking.
paper
Cited
Public
Unavailable
- Authors
- Ho, M K; Tyndale, R F
- Year
- 2007
- Journal
- The pharmacogenomics journal
- PMID
- 17224913
- DOI
- 10.1038/sj.tpj.6500436
Cigarette smoking increases the risk of numerous health problems, including cancer, cardiovascular and pulmonary disorders, making smoking the leading cause of preventable death in the world. Nicotine is primarily responsible for the highly addictive properties of cigarettes. Although the majority of smokers express a desire to quit, few are successful in doing so. Twin and family studies have indicated substantial genetic contributions to smoking behaviors. One major research focus has been to elucidate the specific genes involved; this has been accomplished primarily through genome-wide linkage analyses and candidate gene association studies. Much attention has focused on genes involved in the neurotransmitter pathways for the brain reward system and genes altering nicotine metabolism. This paper reviews the current state of knowledge for genetic factors implicated in smoking behaviors, and examines how genetic variations may affect therapeutic outcomes for drugs used to assist smoking cessation.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Multi-trait genome-wide association analyses leveraging alcohol use disorder findings identify novel loci for smoking behaviors in the Million Veteran Program. | Cheng Y et al. | β | 2023 | β |
| Cytochrome P450 2A6 and 2B6 polymorphisms and smoking cessation success in patients treated with varenicline. | Tomaz PRX et al. | β | 2019 | β |
| Nicotine Effects on White Matter Microstructure in Young Adults. | Kangiser MM et al. | β | 2019 | β |
| Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women. | Tomaz PRX et al. | β | 2018 | β |
| Genetic vulnerability to schizophrenia is associated with cannabis use patterns during adolescence. | Hiemstra M et al. | β | 2018 | β |
| Nicotine dependence is associated with functional variation in FMO3, an enzyme that metabolizes nicotine in the brain. | Teitelbaum AM et al. | β | 2018 | β |
| Brain-volume changes in young and middle-aged smokers: a DARTEL-based voxel-based morphometry study. | Peng P et al. | β | 2017 | β |
| GRONS: a comprehensive genetic resource of nicotine and smoking. | Fang Z et al. | β | 2017 | β |
| Neuregulin signaling pathway in smoking behavior. | Gupta R et al. | β | 2017 | β |
| To quit or not: Vulnerability of women to smoking tobacco. | Park SJ et al. | β | 2016 | β |
| A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism. | Loukola A et al. | β | 2015 | β |
| Association of 5-HTTLPR polymorphism with smoking behaviors: A meta-analysis. | Li H et al. | β | 2015 | β |
| Biomarkers of Response to Smoking Cessation Pharmacotherapies: Progress to Date. | Mamoun M et al. | β | 2015 | β |
| CYP2A6 Polymorphisms May Strengthen Individualized Treatment for Nicotine Dependence. | Akrodou YM | β | 2015 | β |
| Gene-gene interaction of ΞΌ-opioid receptor and GluR5 kainate receptor subunit is associated with smoking behavior in a Greek population: presence of a dose allele effect. | Misailidis G et al. | β | 2015 | β |
| Nicotine dependence in an isolated population of Kashubians from North Poland: a population survey. | Sieminska A et al. | β | 2015 | β |
| Pharmacogenetics of nicotine and associated smoking behaviors. | Tanner JA et al. | β | 2015 | β |
| Prioritizing Genes Related to Nicotine Addiction Via a Multi-source-Based Approach. | Liu X et al. | β | 2015 | β |
| Role of cytochrome P450 2C8*3 (CYP2C8*3) in paclitaxel metabolism and paclitaxel-induced neurotoxicity. | Lee MY et al. | β | 2015 | β |
| Anticipated motivation for genetic testing among smokers, nonsmokers, and former smokers: an exploratory qualitative study of decision making. | Giordimaina AM et al. | β | 2014 | β |
| Genetic basis of delay discounting in frequent gamblers: examination of a priori candidates and exploration of a panel of dopamine-related loci. | Gray JC et al. | β | 2014 | β |
| Genetics and smoking. | Loukola A et al. | β | 2014 | β |
| Variants in two adjacent genes, EGLN2 and CYP2A6, influence smoking behavior related to disease risk via different mechanisms. | Bloom AJ et al. | β | 2014 | β |
| Heritability of chronic obstructive pulmonary disease and related phenotypes in smokers. | Zhou JJ et al. | β | 2013 | β |
| Nine generations of selection for high and low nicotine intake in outbred Sprague-Dawley rats. | Nesil T et al. | β | 2013 | β |
| Smoking-specific parenting and smoking onset in adolescence: the role of genes from the dopaminergic system (DRD2, DRD4, DAT1 genotypes). | Hiemstra M et al. | β | 2013 | β |
| The contribution of common UGT2B10 and CYP2A6 alleles to variation in nicotine glucuronidation among European Americans. | Bloom AJ et al. | β | 2013 | β |
| A DRD2 and ANKK1 haplotype is associated with nicotine dependence. | Voisey J et al. | β | 2012 | β |
| CD-1 mice Show Individual Differences in Nicotine Preference in a Modified Two-Bottle Oral Self-Administration Model. | Cao J et al. | β | 2012 | β |
| Do initial responses to drugs predict future use or abuse? | de Wit H et al. | β | 2012 | β |
| Genetics of GABAergic signaling in nicotine and alcohol dependence. | Cui WY et al. | β | 2012 | β |
| Genotype-Based Bayesian Analysis of Gene-Environment Interactions with Multiple Genetic Markers and Misclassification in Environmental Factors. | Lobach I et al. | β | 2012 | β |
| Involvement of rat dopaminergic system of nucleus accumbens in nicotine-induced anxiogenic-like behaviors. | Zarrindast MR et al. | β | 2012 | β |
| Smoking, dopamine transporter, and hand tremor. | Lin CY et al. | β | 2012 | β |
| Strain-dependent effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning. | Portugal GS et al. | β | 2012 | β |
| The genetics of substance dependence. | Wang JC et al. | β | 2012 | β |
| Computational modeling of P450s for toxicity prediction. | Mishra NK | β | 2011 | β |
| Dopamine transporter genotype modulation of neural responses to smoking cues: confirmation in a new cohort. | Franklin TR et al. | β | 2011 | β |
| Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood. | Nemoda Z et al. | β | 2011 | β |
| The contribution of common CYP2A6 alleles to variation in nicotine metabolism among European-Americans. | Bloom J et al. | β | 2011 | β |
| The serotonin transporter gene and startle response during nicotine deprivation. | Minnix JA et al. | β | 2011 | β |
| Association of a variant in the muscarinic acetylcholine receptor 2 gene (CHRM2) with nicotine addiction. | Mobascher A et al. | β | 2010 | β |
| Association of polymorphisms of the serotonergic system with smoking initiation in Caucasians. | Iordanidou M et al. | β | 2010 | β |
| Breaking barriers in the genomics and pharmacogenetics of drug addiction. | Ho MK et al. | β | 2010 | β |
| Common and unique biological pathways associated with smoking initiation/progression, nicotine dependence, and smoking cessation. | Wang J et al. | β | 2010 | β |
| Hepatic CYP2A6 levels and nicotine metabolism: impact of genetic, physiological, environmental, and epigenetic factors. | Al Koudsi N et al. | β | 2010 | β |
| Hepatic CYP2B6 is altered by genetic, physiologic, and environmental factors but plays little role in nicotine metabolism. | Al Koudsi N et al. | β | 2010 | β |
| Investigation of binding features: effects on the interaction between CYP2A6 and inhibitors. | Ai C et al. | β | 2010 | β |
| Neural markers of genetic vulnerability to drug addiction. | MΓΌller DJ et al. | β | 2010 | β |
| Nicotine addiction. | Benowitz NL | β | 2010 | β |
| Pharmacogenetics: a tool for identifying genetic factors in drug dependence and response to treatment. | Mroziewicz M et al. | β | 2010 | β |
| Pharmacogenetics of drug dependence: role of gene variations in susceptibility and treatment. | Khokhar JY et al. | β | 2010 | β |
| Prospective association of dopamine-related polymorphisms with smoking cessation in general care. | Breitling LP et al. | β | 2010 | β |
| Structural differences determine the relative selectivity of nicotinic compounds for native alpha 4 beta 2*-, alpha 6 beta 2*-, alpha 3 beta 4*- and alpha 7-nicotine acetylcholine receptors. | Grady SR et al. | β | 2010 | β |
| UGT2B10 genotype influences nicotine glucuronidation, oxidation, and consumption. | Berg JZ et al. | β | 2010 | β |
| Abuse liability assessment of tobacco products including potential reduced exposure products. | Carter LP et al. | β | 2009 | β |
| Breathe deeply into your genes!: genetic variants and air pollution effects. | Baccarelli A | β | 2009 | β |
| Development of a new predictive model for interactions with human cytochrome P450 2A6 using pharmacophore ensemble/support vector machine (PhE/SVM) approach. | Leong MK et al. | β | 2009 | β |
| Gene-gene interactions of CYP2A6 and MAOA polymorphisms on smoking behavior in Chinese male population. | Tang X et al. | β | 2009 | β |
| Genome-wide association study of smoking initiation and current smoking. | Vink JM et al. | β | 2009 | β |
| Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. | Benowitz NL | β | 2009 | β |
| QSAR of cytochrome inhibitors. | Roy K et al. | β | 2009 | β |
| Significant association of ANKK1 and detection of a functional polymorphism with nicotine dependence in an African-American sample. | Huang W et al. | β | 2009 | β |
| A functional polymorphism, rs6280, in DRD3 is significantly associated with nicotine dependence in European-American smokers. | Huang W et al. | β | 2008 | β |
| Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. | Benowitz NL | β | 2008 | β |
| Gene-gene interactions among CHRNA4, CHRNB2, BDNF, and NTRK2 in nicotine dependence. | Li MD et al. | β | 2008 | β |
| Genetic variability in nicotinic acetylcholine receptors and nicotine addiction: converging evidence from human and animal research. | Portugal GS et al. | β | 2008 | β |
| Guest editorial. Genes and lung cancer. | Collins AC et al. | β | 2008 | β |
| Identifying susceptibility loci for nicotine dependence: 2008 update based on recent genome-wide linkage analyses. | Li MD | β | 2008 | β |
| Lessons from multidisciplinary cross-fertilization: chronic obstructive pulmonary disease, lung cancer, and heart disease. | Rennard SI | β | 2008 | β |
| Lung cancer epigenetics and genetics. | Risch A et al. | β | 2008 | β |
| Primary care physicians' willingness to offer a new genetic test to tailor smoking treatment, according to test characteristics. | Shields AE et al. | β | 2008 | β |
| Significant association of DRD1 with nicotine dependence. | Huang W et al. | β | 2008 | β |
| Smoking cessation guidelines--2008. | Reichert J et al. | β | 2008 | β |
| Genetics and smoking behavior. | Schnoll RA et al. | β | 2007 | β |